NEYLAN JOHN F. (Chief Medical Officer) sold 0.8% of their position (1.16K shares) of KERYX BIOPHARMACEUTICALS INC on the open market
Open‑market sale worth $3.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/16/2018ACC: 0001114220-18-000110
Officer· Chief Medical Officer
Since Jul 2018
-1.16K
Net shares
Net seller
$3.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.16K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.16K
Price / share
$2.77
Trade value
$3.20K
% of position
0.8%
11/15/2018
149.44K→148.28K
Total
Net shares
−1.16K
Net value
-$3.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2018 | S · Sale | −1.16K | $2.77 | $3.20K | 0.8% | 149.44K | 148.28K |
| Total | −1.16K | -$3.20K | ||||||
Derivative Transactions0
No derivative transactions reported